Does METOPROLOL Cause Hyperlipidaemia? 138 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Hyperlipidaemia have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.
138
Reports of Hyperlipidaemia with METOPROLOL
0.3%
of all METOPROLOL reports
13
Deaths
94
Hospitalizations
How Dangerous Is Hyperlipidaemia From METOPROLOL?
Of the 138 reports, 13 (9.4%) resulted in death, 94 (68.1%) required hospitalization, and 5 (3.6%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which METOPROLOL Alternatives Have Lower Hyperlipidaemia Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE